
Ron Finklestien
Investing in Tech for an Unforgettable February
Source: thinkhubstudio / Shutterstock.com When it comes to the stock market, technology companies have always been the belle of the ball, and February promises ...
Rivian’s Customizable Interior Ambient Lighting Feature Aims to Enhance User Experience for R1 EVs
Rivian’s Customizable Interior Ambient Lighting Feature Aims to Enhance User Experience for R1 EVs
EV startup Rivian Automotive Inc. RIVN announced earlier this week that it is working on customizable interior ambient lighting for its R1 model, similar ...
6 Compelling Reasons to Consider Investing in British American Tobacco Stock
6 Compelling Reasons to Consider Investing in British American Tobacco Stock
The future of the tobacco industry may not be as bright as it once was, considering the public’s heightened awareness of the health risks ...
Eli Lilly’s Journey to a $1 Trillion Biopharma Stock
Eli Lilly’s Journey to a $1 Trillion Biopharma Stock
Eli Lilly’s Potential for Stratospheric Growth Morgan Stanley, in a recent research note, has expressed optimism about Eli Lilly’s (NYSE:LLY) potential for stratospheric growth. ...
The 3 Most Promising Meme Stocks in February 2024
The 3 Most Promising Meme Stocks in February 2024
The allure of these stocks transcends mere enthusiasm and sensation amongst individual investors Source: Michael Vi / Shutterstock When considering the prime meme stocks ...
Blueprint Medicines Corp. Sees Q4 Earnings Soar as Ayvakit Steals the Show
Blueprint Medicines Corporation (NASDAQ:BPMC) blew past expectations with a fourth-quarter 2023 loss of $1.82 per share – outstripping the Zacks Consensus Estimate of a ...
Cloudflare Rockets 20% in a Single Day: Should You Invest?
Cloudflare Rockets 20% in a Single Day: Should You Invest?
Sometimes the market loves a company’s results so much that it dramatically reprices the stock. That’s what it did when Cloudflare (NYSE: NET) reported ...
Top Dividend Stocks to Consider for February 16th
Top Dividend Stocks to Consider for February 16th
On this 16th day of February, investors may want to take a good, hard look at the following companies that stand out for their ...
Ionis Pharma’s Olezarsen Receives FDA’s Orphan Drug Designation
Ionis Pharma’s Olezarsen Receives FDA’s Orphan Drug Designation
Ionis Pharma, a leader in RNA-targeted therapeutics, has proudly announced that the FDA has bestowed its orphan drug designation upon Olezarsen for the treatment ...














